广发医药创新混合发起式A(017962)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
56,855.66 |
106,698.32 |
34,824.54 |
| 存出保证金 |
7,211.04 |
11,867.13 |
3,063.24 |
| 交易性金融资产 |
25,486,944.59 |
28,965,921.29 |
22,693,149.03 |
| 其中：股票投资 |
25,079,300.10 |
28,965,921.29 |
22,693,149.03 |
| 债券投资 |
407,644.49 |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
2,109.25 |
47,074.48 |
102,844.33 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
27,054,783.37 |
32,877,466.51 |
46,553,165.67 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
1.23 |
675.02 |
92,251.94 |
| 应付赎回款 |
327,942.03 |
122,762.95 |
138,975.37 |
| 应付管理人报酬 |
28,901.49 |
33,698.21 |
45,783.27 |
| 应付托管费 |
4,816.90 |
5,616.38 |
7,630.54 |
| 应付销售服务费 |
1,902.06 |
2,967.31 |
3,285.24 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
75,123.10 |
86,697.43 |
40,960.71 |
| 负债合计 |
438,686.81 |
252,417.30 |
328,887.07 |
| 所有者权益 |
| 实收基金 |
28,855,699.22 |
33,238,937.16 |
44,321,536.72 |
| 未分配利润 |
-2,239,602.66 |
-613,887.95 |
1,902,741.88 |
| 所有者权益合计 |
26,616,096.56 |
32,625,049.21 |
46,224,278.60 |
| 负债及所有者权益总计 |
27,054,783.37 |
32,877,466.51 |
46,553,165.67 |
微信公众号
证券之星APP
基本资料
